Worth a shot: Immunotherapy effective in severe eczema

The case report adds to evidence in support of subcutaneous allergy therapy

Subcutaneous allergen immunotherapy appears to have reduced a patient’s symptoms of severe eczema, according to a new case study.

Before immunotherapy, the 48-year-old patient with a history of severe eczema since childhood, scored 79.4 on the Scoring Atopic Dermatitis (SCORAD) index — well into the severe range.